RAHWAY, N.J.–(BUSINESS WIRE) December 17, 2024 — Merck (NYSE: MRK), known as MSD...
Author - David Miller
Increased Odds of Leaving ED Before Medically Advised Tied to...
MONDAY, Feb. 24, 2025 -- In the United States, the COVID-19 pandemic was associated with increased...
Smoking Linked to Cryptogenic Ischemic Stroke in Young Adults
MONDAY, Feb. 24, 2025 -- Smoking and high-intensity smoking are associated with cryptogenic...
U.S. Food and Drug Administration Issues Complete Response...
Copenhagen, Denmark, December 19, 2024 – Zealand Pharma A/S (Nasdaq: ZEAL) (“Zealand”)...
AI-Assisted Screening Tool Speeds Trial Eligibility Determination
MONDAY, Feb. 24, 2025 -- Compared with manual screening, an artificial intelligence (AI)-assisted...
Physical Activity Linked to Attenuation of Colon Cancer Survival...
MONDAY, Feb. 24, 2025 -- For patients with stage III colon cancer participating in clinical trials...
PTC Therapeutics Announces Vatiquinone NDA Submission to FDA for...
WARREN, N.J., Dec. 19, 2024 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) announced...
Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15...
CHATHAM, N.J., Dec. 23, 2024 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq:...
Muscle-Building Supplements Tied to Muscle Dysmorphia...
MONDAY, Feb. 24, 2025 -- The use of multiple muscle-building supplements is associated with muscle...
Lexicon Announces Receipt of Complete Response Letter for...
THE WOODLANDS, TEXAS, DEC. 20, 2024 — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today...